Literature DB >> 29415554

The relationship between gastrointestinal symptom attribution, bothersomeness, and antiretroviral adherence among adults with HIV.

Holly Swan1, Joel I Reisman1, Sarah E McDannold1,2, Mark E Glickman3, D Keith McInnes1,2, Allen L Gifford4.   

Abstract

Patients who attribute their symptoms to HIV medications, rather than disease, may be prone to switching antiretrovirals (ARVs) and experience poor retention/adherence to care. Gastrointestinal (GI) symptoms (e.g., nausea/vomiting) are often experienced as a side effect of ARVs, but little is known about the relationship of symptom attribution and bothersomeness to adherence. We hypothesized that attribution of a GI symptom to ARVs is associated with a reduction in adherence, and that this relationship is moderated by the bothersomeness of the symptom. Data for our analysis come from the pre-randomization enrollment period of a larger study testing an adherence improvement intervention. Analyses revealed that patients with diarrhea who attributed the symptom to ARVs (compared to those who did not) had significantly worse adherence. We did not find a significant moderating effect of bothersomeness on this relationship. Incorporating patient beliefs about causes of symptoms into clinical care may contribute to improved symptom and medication management, and better adherence.

Entities:  

Keywords:  HIV/AIDS; MEMS; adherence; antiretroviral medication; symptom attribution

Mesh:

Substances:

Year:  2018        PMID: 29415554      PMCID: PMC6166244          DOI: 10.1080/09540121.2018.1437254

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  28 in total

1.  The drugs or the disease? Causal attributions of symptoms held by HIV-positive adults on HAART.

Authors:  Mallory O Johnson; Tanya Stallworth; Torsten B Neilands
Journal:  AIDS Behav       Date:  2003-06

2.  Evaluation of adverse events associated with antiretroviral therapy and the relationship to treatment adherence.

Authors:  Luana Lenzi; Astrid Wiens; Roberto Pontarolo
Journal:  Int J Clin Pharmacol Ther       Date:  2013-02       Impact factor: 1.366

3.  Enhanced HIV testing, treatment, and support for HIV-infected substance users.

Authors:  Nora D Volkow; Julio Montaner
Journal:  JAMA       Date:  2010-04-14       Impact factor: 56.272

4.  Antiretroviral therapy adherence: testing a social context model among Black men who use illicit drugs.

Authors:  J Craig Phillips
Journal:  J Assoc Nurses AIDS Care       Date:  2010-11-30       Impact factor: 1.354

5.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

6.  Differential medication nonadherence and illness beliefs in co-morbid HIV and type 2 diabetes.

Authors:  Abigail W Batchelder; Jeffrey S Gonzalez; Karina M Berg
Journal:  J Behav Med       Date:  2013-01-01

7.  Self-reported medication adherence and symptom experience in adults with HIV.

Authors:  Caryl Gay; Carmen J Portillo; Ryan Kelly; Traci Coggins; Harvey Davis; Bradley E Aouizerat; Clive R Pullinger; Kathryn A Lee
Journal:  J Assoc Nurses AIDS Care       Date:  2011-03-05       Impact factor: 1.354

8.  Different Patterns of Drug Use and Barriers to Continuous HIV Care Post-Incarceration.

Authors:  Holly Swan
Journal:  J Drug Issues       Date:  2015-01-01

9.  Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.

Authors:  Julio S G Montaner; Viviane D Lima; Rolando Barrios; Benita Yip; Evan Wood; Thomas Kerr; Kate Shannon; P Richard Harrigan; Robert S Hogg; Patricia Daly; Perry Kendall
Journal:  Lancet       Date:  2010-07-16       Impact factor: 79.321

10.  Accessing antiretroviral therapy following release from prison.

Authors:  Jacques Baillargeon; Thomas P Giordano; Josiah D Rich; Z Helen Wu; Katherine Wells; Brad H Pollock; David P Paar
Journal:  JAMA       Date:  2009-02-25       Impact factor: 56.272

View more
  1 in total

1.  Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression.

Authors:  Andrea Antinori; Maria V Cossu; Barbara Menzaghi; Gaetana Sterrantino; Nicola Squillace; Valentina Di Cristo; Annamaria Cattelan; Emanuele Focà; Antonella Castagna; Giancarlo Orofino; Daniela Valenti; Gabriella D'Ettore; Lucia Aprea; Sergio Ferrara; Maria E Locatelli; Giordano Madeddu; Emanuele Pontali; Paolo Scerbo; Barbara Rossetti; Alessia Uglietti; Roberta Termini; Francesco Rucci; Andrea Gori; Daniela Mancusi
Journal:  Patient       Date:  2020-06       Impact factor: 3.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.